SRTS · Sensus Healthcare, Inc.
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-05-12 | Sachetta Eric |
Director |
Buy↑
|
Common Stock
|
1,500 |
| 2026-02-24 | Sachetta Eric |
Director |
Buy↑
Filing footnotes — Common Stock (Direct)
Represents the average price per share. |
Common Stock
|
2,000 |
| 2026-01-05 | Biscotti Larry Joseph |
Director |
Other↑
|
No Securities Owned
|
0 |
| 2025-12-12 | Sardano Michael |
Director, PRESIDENT AND GENERAL COUNSEL |
Award↑
Filing footnotes — Common Stock (Direct)
Represents 40,000 shares of restricted stock granted to the reporting person pursuant to the Sensus Healthcare, Inc. 2017 Equity Incentive Plan, all of which will vest in four equal annual installments beginning on the first anniversary of the date of grant. |
Common Stock
|
40,000 |
| 2025-11-21 | Sachetta Eric |
Director |
Buy↑
|
Common Stock
|
7,000 |
| 2025-11-18 | Sardano Joseph C |
Director, CHIEF EXECUTIVE OFFICER |
Buy↑
Filing footnotes — Common Stock (Direct)
Represents the average price per share. |
Common Stock
|
25,000 |
| 2025-11-13 | Sachetta Eric |
Director |
Buy↑
|
Common Stock
|
2,500 |
| 2025-11-11 | Sardano Michael |
Director, PRESIDENT AND GENERAL COUNSEL |
Buy↑
|
Common Stock
|
1,000 |
| 2025-11-11 | Sardano Michael |
Director, PRESIDENT AND GENERAL COUNSEL |
Buy↑
|
Common Stock
|
1,000 |
| 2025-11-11 | Sardano Michael |
Director, PRESIDENT AND GENERAL COUNSEL |
Buy↑
Filing footnotes — Common Stock (Indirect)
Shares held by Mr. Sardano's spouse, as to which he disclaims beneficial ownership. |
Common Stock
(I)
|
234 |
| 2025-11-11 | Sardano Michael |
Director, PRESIDENT AND GENERAL COUNSEL |
Buy↑
Filing footnotes — Common Stock (Indirect)
Shares held by Mr. Sardano's spouse, as to which he disclaims beneficial ownership. |
Common Stock
(I)
|
766 |
| 2025-11-11 | Sardano Michael |
Director, PRESIDENT AND GENERAL COUNSEL |
Buy↑
Filing footnotes — Common Stock (Indirect)
Shares held by Mr. Sardano's spouse, as to which he disclaims beneficial ownership. |
Common Stock
(I)
|
766 |
| 2025-11-11 | Sardano Michael |
Director, PRESIDENT AND GENERAL COUNSEL |
Buy↑
Filing footnotes — Common Stock (Indirect)
Shares held by Mr. Sardano's spouse, as to which he disclaims beneficial ownership. |
Common Stock
(I)
|
234 |
| 2025-08-13 | Sardano Michael |
Director, PRESIDENT AND GENERAL COUNSEL |
Buy↑
|
Common Stock
|
1,000 |
| 2025-05-19 | Chow Carlton |
Chief Technology Officer |
Other↑
|
No Securities Owned
|
0 |
| 2025-02-10 | Rampolla Javier |
CHIEF FINANCIAL OFFICER |
Buy↑
|
Common Stock
|
501 |
| 2025-02-10 | Sardano Michael |
Director, PRESIDENT AND GENERAL COUNSEL |
Buy↑
|
Common Stock
|
1,000 |
| 2024-12-17 | McCall William H |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents 20,000 shares of restricted stock granted to the reporting person pursuant to the Sensus Healthcare, Inc. 2017 Equity Incentive Plan which will vest in four equal annual installments beginning on the first anniversary of the date of grant. |
Common Stock
|
20,000 |
| 2024-12-17 | Sardano Michael |
Director, PRESIDENT AND GENERAL COUNSEL |
Award↑
Filing footnotes — Common Stock (Direct)
Represents 40,000 shares of restricted stock granted to the reporting person pursuant to the Sensus Healthcare, Inc. 2017 Equity Incentive Plan, 10,000 of which vested on the date of grant and 30,000 of which will vest in three equal annual installments beginning on the first anniversary of the date of grant. |
Common Stock
|
40,000 |
| 2024-12-17 | Petrelli Anthony Benedict |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents 20,000 shares of restricted stock granted to the reporting person pursuant to the Sensus Healthcare, Inc. 2017 Equity Incentive Plan which will vest in four equal annual installments beginning on the first anniversary of the date of grant. |
Common Stock
|
20,000 |
| 2024-12-17 | Cornish Megan |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents 20,000 shares of restricted stock granted to the reporting person pursuant to the Sensus Healthcare, Inc. 2017 Equity Incentive Plan which will vest in four equal annual installments beginning on the first anniversary of the date of grant. |
Common Stock
|
20,000 |
| 2024-07-21 | Sardano Michael |
Director, PRESIDENT AND GENERAL COUNSEL |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares withheld to pay the reporting person's withholding tax obligation arising solely in connection with the vesting of restricted stock. |
Common Stock
|
3,935 |
| 2024-07-21 | Rampolla Javier |
CHIEF FINANCIAL OFFICER |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares withheld to pay the reporting person's withholding tax obligation arising solely in connection with the vesting of restricted stock. |
Common Stock
|
3,935 |
| 2024-05-20 | Heinrich John |
Director |
Sell↓
|
Common Stock
|
15,227 |
| 2024-05-17 | Heinrich John |
Director |
Sell↓
|
Common Stock
|
4,773 |
| 2024-01-11 | Sardano Michael |
Director, PRESIDENT AND GENERAL COUNSEL |
Award↑
Filing footnotes — Common Stock (Direct)
Represents 20,000 shares of stock granted to the reporting person by a committee of non-employee directors in compliance with Rule 16b-3 and pursuant to the Sensus Healthcare, Inc. 2017 Equity Incentive Plan. 10,000 of these shares vested immediately. The remaining 10,000 shares will vest on January 11, 2025. |
Common Stock
|
20,000 |
| 2023-12-19 | Martinez Magdalena |
CHIEF OPERATING OFFICER |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares withheld to pay reporting person's withholding tax obligation arising solely in connection with the vesting of restricted stock. On December 20, 2023, the reporting person filed a Form 4 which inadvertently reported that the reporting person owned 9,759 shares of the issuer's common stock as of December 19, 2023. In fact, the reporting person held 12,013 shares of the issuer's common stock (including 7,500 shares of restricted stock) as of December 19, 2023. |
Common Stock
|
741 |
| 2023-09-14 | Sardano Joseph C |
Director, CHIEF EXECUTIVE OFFICER |
Buy↑
Filing footnotes — Common Stock (Direct)
Represents the average price per share. |
Common Stock
|
10,000 |
| 2023-08-28 | Sardano Michael |
Director, PRESIDENT AND GENERAL COUNSEL |
Buy↑
|
Common Stock
|
1,000 |
| 2023-08-08 | Sardano Joseph C |
Director, CHIEF EXECUTIVE OFFICER |
Buy↑
Filing footnotes — Common Stock (Direct)
Represents the average price per share. |
Common Stock
|
10,000 |
| 2023-08-08 | Sardano Michael |
Director, PRESIDENT AND GENERAL COUNSEL |
Buy↑
Filing footnotes — Common Stock (Direct)
Represents the average price per share. |
Common Stock
|
1,000 |
| 2023-07-31 | Rampolla Javier |
CHIEF FINANCIAL OFFICER |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares withheld to pay the reporting person's withholding tax obligation arising solely in connection with the vesting of restricted stock. |
Common Stock
|
3,935 |
| 2023-05-11 | Heinrich John |
Director |
Buy↑
|
Common Stock
|
10,000 |
| 2023-05-10 | Sardano Joseph C |
Director, CHIEF EXECUTIVE OFFICER |
Buy↑
Filing footnotes — Common Stock (Direct)
Represents the average price per share. |
Common Stock
|
7,925 |
| 2023-05-09 | Sardano Joseph C |
Director, CHIEF EXECUTIVE OFFICER |
Buy↑
Filing footnotes — Common Stock (Direct)
Represents the average price per share. |
Common Stock
|
17,075 |
| 2023-05-09 | O'Rear Samuel |
Director |
Buy↑
|
Common Stock
|
17,564 |
| 2023-05-08 | Sardano Michael |
Director, PRESIDENT AND GENERAL COUNSEL |
Buy↑
|
Common Stock
|
1,000 |
| 2023-05-08 | O'Rear Samuel |
Director |
Buy↑
|
Common Stock
|
2,436 |
| 2023-02-01 | Rampolla Javier |
CHIEF FINANCIAL OFFICER |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares withheld to pay the reporting person's withholding tax obligation arising solely in connection with the vesting of restricted stock. |
Common Stock
|
742 |
| 2023-01-26 | Sardano Michael |
Director, PRESIDENT AND GENERAL COUNSEL |
Tax↓
|
Common Stock
|
3,745 |
| 2023-01-26 | Sardano Michael |
Director, PRESIDENT AND GENERAL COUNSEL |
Award↑
Filing footnotes — Common Stock (Direct)
Represents 10,000 shares of stock granted to the reporting person by a committee of non-employee directors in compliance with Rule 16b-3 and pursuant to the Sensus Healthcare, Inc. 2017 Equity Incentive Plan. |
Common Stock
|
10,000 |
| 2022-09-13 | Sardano Michael |
Director, PRESIDENT AND GENERAL COUNSEL |
Convert↑
|
Common Stock
|
5,000 |
| 2022-09-13 | Sardano Michael |
Director, PRESIDENT AND GENERAL COUNSEL |
Sell↓
Filing footnotes — Common Stock (Direct)
This represents the average price per share. The shares sold at prices ranging from $14.07 to $14.156. |
Common Stock
|
5,000 |
| 2022-09-07 | Sardano Joseph C |
Director, CHIEF EXECUTIVE OFFICER |
Sell↓
Filing footnotes — Common Stock (Direct)
This represents the average price per share. The shares were sold at prices ranging from $12.54 to $12.70. |
Common Stock
|
15,794 |
| 2022-09-06 | Sardano Joseph C |
Director, CHIEF EXECUTIVE OFFICER |
Sell↓
Filing footnotes — Common Stock (Direct)
This represents the average price per share. The shares were sole at prices ranging from $12.50 to $12.61. |
Common Stock
|
15,794 |
| 2022-09-02 | Sardano Joseph C |
Director, CHIEF EXECUTIVE OFFICER |
Sell↓
Filing footnotes — Common Stock (Direct)
This represents the average price per share. The shares were sold at prices ranging from $12.40 to $12.47. |
Common Stock
|
10,000 |
| 2022-08-11 | Sardano Joseph C |
Director, CHIEF EXECUTIVE OFFICER |
Sell↓
Filing footnotes — Common Stock (Direct)
This represents the average price per share. The shares were sold from prices ranging from $13.76 to $14.37. |
Common Stock
|
28,999 |
| 2022-08-10 | Sardano Joseph C |
Director, CHIEF EXECUTIVE OFFICER |
Sell↓
Filing footnotes — Common Stock (Direct)
This represents the average price per share. The shares were sold from prices ranging from $14 to $14.48. |
Common Stock
|
93,320 |
| 2022-08-10 | O'Rear Samuel |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
This represents the average price per share. The shares were sold from prices ranging from $14 to $14.475. |
Common Stock
|
39,978 |
| 2022-08-09 | O'Rear Samuel |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
This represents the average price per share. The shares were sold from prices ranging from $13.9 to $14. |
Common Stock
|
10,022 |